About EMSA

•Download as PPTX, PDF•

1 like•965 views

This document discusses the European Medical Students' Association (EMSA). It provides information on EMSA's structure, core activities, and European Support Division (ESD). EMSA is a European organization that represents medical students through local coordinators. It focuses on medical education, science, ethics, public health, and European integration through volunteer work. The ESD consists of EMSA members who work as advisors or project managers in areas like medical education, science, ethics, public health, and policy making. The document encourages students to apply to join the ESD and provides information on EMSA's online tools and programs like twinning exchanges and summer schools.

Health & Medicine Business

1European Medical Students' Association
Süleyman YILDIZ
Secretary General 2011-2013
Medical Education Director 2010-2011
eeb@emsa-europe.eu

1. EMSA and Europe
2. European Support Division
3. New online tool for EMSA members
4. European week of Ethics

3European Medical Students' Association
EMSA and EUROPE

4European Medical Students' Association
ORIGIN
• AN EUROPEAN ORGANIZATION
•European oriented
•European identity
STRUCTURE
• DIRECT REPRESENTATION BY FACULTIES
•Local Coordinators
•Flexible system both at local and international level and autonomous development
CORE
• VOLUNTEERS’ POWER: EUROPEAN SUPPORT DIVISION
•Medical Education, Science, Ethics and Culture, Public Health, European Integration, Policy
SPECIFICS
• EUROPEAN WEEK OF ETHICS, TWINNING PROJECT, MedEdWorld, MOVIE&MEDICINE,
SECRET SCIENCE
POLICY
• POLITICALLY ACTIVE ORGANIZATION
• Brussels office- CPME, EMS Council, Resolutions

6European Medical Students' Association
WHAT IS ESD?
The EMSA European Support Division (ESD) is an international body of
EMSA The ESD is a non-executive international body of EMSA.
It consists of EMSA enthusiasts that work as board assistants, advisors or
European project managers
ESD MEMBERS
Any EMSA member can become a ESD member uppon a sucessfull
application
EUROPEAN SUPPORT DIVISION

7European Medical Students' Association
MEDICAL
EDUCATION
SCIENCE ETHICS
and
CULTURE
EUROPEAN
INTEGRATION
European
Support
Division
PUBLIC
HEALTH
+ POLICY MAKING
TEAM!
WORKING AREAS IN ESD

8European Medical Students' Association
Leadership Summerschool
Movies & Medicine
NEMSC
Science all over the World Congress
Scientific Task Force
Secret Science Club
Substance Misuse
Summer Schools
Teaching the Next Generation
Teddy Bear Hospital
Twinning Project
World AIDS Day Activities
World Healthcare Students'
Best Buddy Project
Bologna Process Workshop
Clerkship & Exchange
CSI Project
Different Christmas
Erasmus Medicus
EuroMedMobility
Euromeds
European Medical Student's
Council
European Words
Eurotalk
Healthy Erasmus
HELP Campaign
JEMSA

TO APPLY
EUROPEAN SUPPORT
DIVISION:
vpi@emsa-europe.eu
FOR MORE DETAILS PLEASE VISIT
OUR BLOG PAGE: BlueMist
www.bluemist.eu

11European Medical Students' Association
www.bluemist.eu
www.emsa-europe.eu
Surprise 
emsa_europe

12European Medical Students' Association
www.emsa-europe.eu

14European Medical Students' Association
EMSA Europe
• General info
• History
• Events shares
BlueMist
• Blog posts
• EEB
• Partners
FMOs website
• LCs
• NCs
• Event calls
• Twinning
Project
• Voting system
• FMO database

15European Medical Students' Association
FMOs’
website
ALL EMSAi
Blog posts
EMSA-Europe

17European Medical Students' Association
•Create your FMO PAGE!
•All details about your local organization and team members
•Post your TWINNING CALL
•More details about twinning offers
•Specific pages for international events
Send your calls directly to EMSA members only with one source.
•Blogging
Bring your ideas to the public: BLOGS from EMSA members!
•Online voting tool
Poll, survey, Policy papers
•FMO Database
You will start to write your FMO’s history in EMSA!
?
NCs
EEB

18European Medical Students' Association
TWINNING PROJECT
•Short exchange program between
faculties
•European integration
•Medical education systems
•Opportunity to discover Europe with
collegeus

19European Medical Students' Association
SUMMER/WINTER SCHOOLS
•Around 18 summer/winter school programmes
•Regular shares and updates
•Cooperation with famous European/non-European faculties
educational programs
•Campaigns

20European Medical Students' Association
SCIENTIFIC CONGRESS

'Investigar, educar, dialogar. Las lecciones que aprendimos de José Mariano Gago (1948-2015)'. Con este título celebramos los días 1 y 2 de junio de 2016 en la Fundación Ramón Areces un simposio para homenajear la trayectoria de quien fue ministro de Ciencia y Tecnología (1995-2002) y ministro de Ciencia, Tecnología y Educación Superior (2005-2011) de Portugal. Gago desempeñó una labor crucial en el diseño de los planes de desarrollo de la ciencia, la tecnología y la innovación, no solo en su país sino en toda Europa.

EAHIL PHIG Overview For ECDC

EAHILPHIG

UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017

ipposi

2010 11 13 european cme forum jan geissler 1.5jangeissler

Neighbourhoods and a Life with Dementia

nbdem

ENCA 2016 - Genoa - Dieter Wiek

anton gruss

2 PRoF 2016 prof Peleman introduction

PRoF Consortium

What Euripa can offer to young GPs ? - Wonca Europe 2011 in Warsaw

jbanquev

Experiences in eLearning addressed to African countries using Telemedicine

Plan de Calidad para el SNS

Kay Parkinson - Cambridge Rare Disease Summit 2015

CamRARE Disease Network

Gioi thieu ttđd phúc lâm enHạnh Hoàng

Tularemi özel

Suleyman Yildiz

Teacher Effectiveness- AMEE 2013

Suleyman Yildiz

Similar to About EMSA

Ocumel Ireland - 2019 CURE OM Symposium

Melanoma Research Foundation

EURAXESS Communications - PPT for researchersMilan Zdravković

Patient Designed Healthcare

Kathi Apostolidis

Ayman CV 7-2015Ayman Sabae

Profile pasykaf 2011

francescosocialcare

European Cancer Patient Advocacy: Introduction to the community, key stakehol...

jangeissler

Eap2018

Trillium Bridge: Reinforcing the Bridges and Scaling up EU/US Cooperation on Patient Summary

Did you know newsletter eau suppl 2015

Europa UOMO

WE Patients Foundation - Presentation of the team and activities

Fundacja MY PACJENCI

Julio E. Celis-Investigar, educar, dialogar

Fundación Ramón Areces

EAHIL PHIG Overview For ECDC

EAHILPHIG

UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017

ipposi

2010 11 13 european cme forum jan geissler 1.5jangeissler

Neighbourhoods and a Life with Dementia

nbdem

ENCA 2016 - Genoa - Dieter Wiek

anton gruss

2 PRoF 2016 prof Peleman introduction

PRoF Consortium

What Euripa can offer to young GPs ? - Wonca Europe 2011 in Warsaw

jbanquev

Experiences in eLearning addressed to African countries using Telemedicine

Plan de Calidad para el SNS

Kay Parkinson - Cambridge Rare Disease Summit 2015

CamRARE Disease Network

Gioi thieu ttđd phúc lâm enHạnh Hoàng

Similar to About EMSA (20)

Ocumel Ireland - 2019 CURE OM Symposium

EURAXESS Communications - PPT for researchers

Patient Designed Healthcare

Ayman CV 7-2015

Profile pasykaf 2011

European Cancer Patient Advocacy: Introduction to the community, key stakehol...

Eap2018

Did you know newsletter eau suppl 2015

WE Patients Foundation - Presentation of the team and activities

Julio E. Celis-Investigar, educar, dialogar

EAHIL PHIG Overview For ECDC

UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017

2010 11 13 european cme forum jan geissler 1.5

Neighbourhoods and a Life with Dementia

ENCA 2016 - Genoa - Dieter Wiek

2 PRoF 2016 prof Peleman introduction

What Euripa can offer to young GPs ? - Wonca Europe 2011 in Warsaw

Experiences in eLearning addressed to African countries using Telemedicine

Kay Parkinson - Cambridge Rare Disease Summit 2015

Gioi thieu ttđd phúc lâm en

Recently uploaded

BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf

DR SETH JOTHAM

The prostate is an exocrine gland of the male mammalian reproductive system It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ). It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes It’s work is regulated by androgens which are responsible for male sex characteristics Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Oleg Kshivets

RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0). CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.

Ocular injury ppt Upendra pal optometrist upums saifai etawah

pal078100

micro teaching on communication m.sc nursing.pdf

Anurag Sharma

Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad

NephroTube - Dr.Gawad

- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo - Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI - Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html - Link to NephroTube website: www.NephroTube.com - Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html

Evaluation of antidepressant activity of clitoris ternatea in animals

Shweta

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?

bkling

Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.

HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...

GL Anaacs

Contact us if you are interested: Email / Skype : kefaya1771@gmail.com Threema: PXHY5PDH New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH ! Contact me on Threema or skype to start big business!! Hot-sale products: NEW HOT EUTYLONE WHITE CRYSTAL!! 5cl-adba precursor (semi finished ) 5cl-adba raw materials ADBB precursor (semi finished ) ADBB raw materials APVP powder 5fadb/4f-adb Jwh018 / Jwh210 Eutylone crystal Protonitazene (hydrochloride) CAS: 119276-01-6 Flubrotizolam CAS: 57801-95-3 Metonitazene CAS: 14680-51-4 Payment terms: Western Union,MoneyGram,Bitcoin or USDT. Deliver Time: Usually 7-15days Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet. Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details. We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf

Dr Jeenal Mistry

Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol that is rapidly distributed in the body and brain. Ethanol alters many neurochemical systems and has rewarding and addictive properties. It is the oldest recreational drug and likely contributes to more morbidity, mortality, and public health costs than all illicit drugs combined. The 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) integrates alcohol abuse and alcohol dependence into a single disorder called alcohol use disorder (AUD), with mild, moderate, and severe subclassifications (American Psychiatric Association, 2013). In the DSM-5, all types of substance abuse and dependence have been combined into a single substance use disorder (SUD) on a continuum from mild to severe. A diagnosis of AUD requires that at least two of the 11 DSM-5 behaviors be present within a 12-month period (mild AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria). The four main behavioral effects of AUD are impaired control over drinking, negative social consequences, risky use, and altered physiological effects (tolerance, withdrawal). This chapter presents an overview of the prevalence and harmful consequences of AUD in the U.S., the systemic nature of the disease, neurocircuitry and stages of AUD, comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and pharmacotherapies for AUD.

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists

Saeid Safari

ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx

Swetaba Besh

BRACHYTHERAPY OVERVIEW AND APPLICATORS

Krishan Murari

Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya

Dr KHALID B.M

KDIGO 2024 guidelines for diabetologists

د.محمود نجيب

How to Give Better Lectures: Some Tips for Doctors

LanceCatedral

Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey

greendigital

Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye. Follow us on: Pinterest Introduction Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing . Early Life and Career Childhood and Athletic Beginnings Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle. Transition to Acting Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness. Fitness Regimen Workout Routine Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show. Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles. Importance of Flexibility and Mobility In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

i3 Health

i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource. This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and Associate Division Director for Ambulatory Operations The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma. STATEMENT OF NEED Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL. Target Audience Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL). Learning Objectives 1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL 2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults 3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection

Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx

Dr. Rabia Inam Gandapore

Physiology of Chemical Sensation of smell.pdf

MedicoseAcademics

Title: Sense of Smell Presenter: Dr. Faiza, Assistant Professor of Physiology Qualifications: MBBS (Best Graduate, AIMC Lahore) FCPS Physiology ICMT, CHPE, DHPE (STMU) MPH (GC University, Faisalabad) MBA (Virtual University of Pakistan) Learning Objectives: Describe the primary categories of smells and the concept of odor blindness. Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction. Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain. Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential. Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes. Key Topics: Olfactory Genes: 3% of the human genome accounts for olfactory genes. 400 genes for odorant receptors. Olfactory Membrane: Located in the superior part of the nasal cavity. Medially: Folds downward along the superior septum. Laterally: Folds over the superior turbinate and upper surface of the middle turbinate. Total surface area: 5-10 square centimeters. Olfactory Mucosa: Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell. Sustentacular Cells: Produce mucus and maintain ionic and molecular environment. Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months. Bowman’s Gland: Secretes mucus. Stimulation of Olfactory Cells: Odorant dissolves in mucus and attaches to receptors on olfactory cilia. Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve. Quality of a Good Odorant: Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble. Facilitated by odorant-binding proteins in mucus. Membrane Potential and Action Potential: Resting membrane potential: -55mV. Action potential frequency in the olfactory nerve increases with odorant strength. Adaptation Towards the Sense of Smell: Rapid adaptation within the first second, with further slow adaptation. Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system. Primary Sensations of Smell: Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid. Odor Detection Threshold: Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm). Some toxic substances are odorless at lethal concentrations. Characteristics of Smell: Odor blindness for single substances due to lack of appropriate receptor protein. Behavioral and emotional influences of smell. Transmission of Olfactory Signals: From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition. Primitive, less old, and new olfactory systems with different path

Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...

VarunMahajani

Recently uploaded (20)

BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Ocular injury ppt Upendra pal optometrist upums saifai etawah

micro teaching on communication m.sc nursing.pdf

Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad

Evaluation of antidepressant activity of clitoris ternatea in animals

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?

HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists

ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx

BRACHYTHERAPY OVERVIEW AND APPLICATORS

Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya

KDIGO 2024 guidelines for diabetologists

How to Give Better Lectures: Some Tips for Doctors

Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx

Physiology of Chemical Sensation of smell.pdf

Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...

About EMSA

1. 1European Medical Students' Association Süleyman YILDIZ Secretary General 2011-2013 Medical Education Director 2010-2011 eeb@emsa-europe.eu

2. 1. EMSA and Europe 2. European Support Division 3. New online tool for EMSA members 4. European week of Ethics

3. 3European Medical Students' Association EMSA and EUROPE

4. 4European Medical Students' Association ORIGIN • AN EUROPEAN ORGANIZATION •European oriented •European identity STRUCTURE • DIRECT REPRESENTATION BY FACULTIES •Local Coordinators •Flexible system both at local and international level and autonomous development CORE • VOLUNTEERS’ POWER: EUROPEAN SUPPORT DIVISION •Medical Education, Science, Ethics and Culture, Public Health, European Integration, Policy SPECIFICS • EUROPEAN WEEK OF ETHICS, TWINNING PROJECT, MedEdWorld, MOVIE&MEDICINE, SECRET SCIENCE POLICY • POLITICALLY ACTIVE ORGANIZATION • Brussels office- CPME, EMS Council, Resolutions

5. 5European Medical Students' Association

6. 6European Medical Students' Association WHAT IS ESD? The EMSA European Support Division (ESD) is an international body of EMSA The ESD is a non-executive international body of EMSA. It consists of EMSA enthusiasts that work as board assistants, advisors or European project managers ESD MEMBERS Any EMSA member can become a ESD member uppon a sucessfull application EUROPEAN SUPPORT DIVISION

7. 7European Medical Students' Association MEDICAL EDUCATION SCIENCE ETHICS and CULTURE EUROPEAN INTEGRATION European Support Division PUBLIC HEALTH + POLICY MAKING TEAM! WORKING AREAS IN ESD

8. 8European Medical Students' Association Leadership Summerschool Movies & Medicine NEMSC Science all over the World Congress Scientific Task Force Secret Science Club Substance Misuse Summer Schools Teaching the Next Generation Teddy Bear Hospital Twinning Project World AIDS Day Activities World Healthcare Students' Best Buddy Project Bologna Process Workshop Clerkship & Exchange CSI Project Different Christmas Erasmus Medicus EuroMedMobility Euromeds European Medical Student's Council European Words Eurotalk Healthy Erasmus HELP Campaign JEMSA

9. TO APPLY EUROPEAN SUPPORT DIVISION: vpi@emsa-europe.eu FOR MORE DETAILS PLEASE VISIT OUR BLOG PAGE: BlueMist www.bluemist.eu

10. Sharing is SEXY! Sharing is caring…

11. 11European Medical Students' Association www.bluemist.eu www.emsa-europe.eu Surprise  emsa_europe

12. 12European Medical Students' Association www.emsa-europe.eu

13.

14. 14European Medical Students' Association EMSA Europe • General info • History • Events shares BlueMist • Blog posts • EEB • Partners FMOs website • LCs • NCs • Event calls • Twinning Project • Voting system • FMO database

15. 15European Medical Students' Association FMOs’ website ALL EMSAi Blog posts EMSA-Europe

16.

17. 17European Medical Students' Association •Create your FMO PAGE! •All details about your local organization and team members •Post your TWINNING CALL •More details about twinning offers •Specific pages for international events Send your calls directly to EMSA members only with one source. •Blogging Bring your ideas to the public: BLOGS from EMSA members! •Online voting tool Poll, survey, Policy papers •FMO Database You will start to write your FMO’s history in EMSA! ? NCs EEB

18. 18European Medical Students' Association TWINNING PROJECT •Short exchange program between faculties •European integration •Medical education systems •Opportunity to discover Europe with collegeus

19. 19European Medical Students' Association SUMMER/WINTER SCHOOLS •Around 18 summer/winter school programmes •Regular shares and updates •Cooperation with famous European/non-European faculties educational programs •Campaigns

20. 20European Medical Students' Association SCIENTIFIC CONGRESS

21.

22.

23.

24. 24ONE EUROPE ONE VOICE!

About EMSA

Recommended

Recommended

More Related Content

Similar to About EMSA

Similar to About EMSA (20)

More from Suleyman Yildiz

More from Suleyman Yildiz (8)

Recently uploaded

Recently uploaded (20)

About EMSA